The pharmacokinetics of yohimbine in man
- PMID: 3653227
- DOI: 10.1007/BF02455991
The pharmacokinetics of yohimbine in man
Abstract
The kinetic disposition of yohimbine was examined in eight young male subjects following a single oral dose of 10 mg yohimbine hydrochloride. The drug was rapidly absorbed (absorption half-time 0.17 +/- 0.11 h) and rapidly eliminated from the plasma (elimination half-life 0.60 +/- 0.26 h). This clearance of yohimbine from plasma was constant over approximately 10 elimination half-lives, suggesting that distribution into a second pharmacokinetically distinct compartment was not responsible for the rapid decline in plasma yohimbine levels. Urinary excretion and the partitioning of the drug into red blood cells (RBC) was investigated. In the 24 h following oral administration of the drug, virtually no yohimbine was eliminated in the urine (0.35 +/- 0.50% of the administered dose). Furthermore, only 20% of blood-borne yohimbine was located in RBC. These results suggest that yohimbine is eliminated primarily through metabolism since the rapid plasma clearance of yohimbine was not the result of renal elimination or sequestration by RBC.
Similar articles
-
Yohimbine bioavailability in humans.Eur J Clin Pharmacol. 1990;39(4):409-11. doi: 10.1007/BF00315421. Eur J Clin Pharmacol. 1990. PMID: 2076728
-
Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers.Eur J Clin Pharmacol. 1992;43(6):651-6. doi: 10.1007/BF02284967. Eur J Clin Pharmacol. 1992. PMID: 1493849
-
Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations.J Pharm Sci. 1991 Dec;80(12):1119-24. doi: 10.1002/jps.2600801206. J Pharm Sci. 1991. PMID: 1815069 Clinical Trial.
-
Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.Arzneimittelforschung. 2001 Sep;51(9):699-725. doi: 10.1055/s-0031-1300105. Arzneimittelforschung. 2001. PMID: 11642003 Review.
-
Pharmacokinetics of dirithromycin.J Antimicrob Chemother. 1993 Mar;31 Suppl C:65-75. doi: 10.1093/jac/31.suppl_c.65. J Antimicrob Chemother. 1993. PMID: 8478313 Review.
Cited by
-
Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.Br J Pharmacol. 1992 Aug;106(4):917-23. doi: 10.1111/j.1476-5381.1992.tb14435.x. Br J Pharmacol. 1992. PMID: 1393289 Free PMC article.
-
Effects of Acute Yohimbine Hydrochloride Supplementation on Repeated Supramaximal Sprint Performance.Int J Environ Res Public Health. 2022 Jan 25;19(3):1316. doi: 10.3390/ijerph19031316. Int J Environ Res Public Health. 2022. PMID: 35162339 Free PMC article. Clinical Trial.
-
Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.Eur J Clin Pharmacol. 1990;39(5):447-51. doi: 10.1007/BF00280934. Eur J Clin Pharmacol. 1990. PMID: 1963844
-
Comparison of the effects of clonidine and yohimbine on pupillary diameter at different illumination levels.Br J Clin Pharmacol. 2000 Jul;50(1):65-8. doi: 10.1046/j.1365-2125.2000.00225.x. Br J Clin Pharmacol. 2000. PMID: 10886121 Free PMC article. Clinical Trial.
-
Hypertensive urgency: an important aetiology of rebound hypertension.BMJ Case Rep. 2014 Oct 21;2014:bcr2014206022. doi: 10.1136/bcr-2014-206022. BMJ Case Rep. 2014. PMID: 25336552 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources